Stonepine Capital Management’s Aprea Therapeutics APRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-102,242	Closed	-$14.4K	–	61
2025 Q1	$14.4K	Sell	102,242 -46,979	-31%	-$6.62K	0.01%	65
2024 Q4	$491K	Buy	149,221 +12,047	+9%	+$39.6K	0.4%	40
2024 Q3	$377K	Hold	137,174	–	–	0.24%	34
2024 Q2	$558K	Buy	+137,174	New	+$558K	0.51%	21